Robert E. Waltermire, Senior VP, Chief Pharma Dev: Madrigal Pharmaceuticals MDGL Sell · Filed 25/01/17

Trade details

Type: Insider sale
Amount: $120,847.22
Shares · price: 442 sh · $273.41 a share
Held after: 5,058 sh
Stock: Madrigal Pharmaceuticals MDGL
Person: Robert E. WaltermireSenior VP, Chief Pharma Dev
Trade date: 25/01/17
Filed: 25/01/17
Days to filing: 0 days

Sold 8.0% of holdings

Share of holding sold: 8.0%

Madrigal Pharmaceuticals trades, last 26 weeks

What else happened in Madrigal Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/12/18~25/02/16

Robert E. Waltermire's recent trades

Robert E. WaltermireSenior VP, Chief Pharma Dev
SellMadrigal Pharmaceuticals
Sell
Madrigal Pharmaceuticals
MDGL
$1.6M
4,701 sh
$1.6M
Filed 25/03/07
Traded 25/03/05
Robert E. WaltermireSenior VP, Chief Pharma Dev
SellMadrigal Pharmaceuticals
Sell
Madrigal Pharmaceuticals
MDGL
$598.5K
1,777 sh
$598.5K
Filed 25/03/07
Traded 25/03/05
Robert E. WaltermireSenior VP, Chief Pharma Dev
SellMadrigal Pharmaceuticals
Sell
Madrigal Pharmaceuticals
MDGL
$564.6K
1,657 sh
$564.6K
Filed 25/03/07
Traded 25/03/05
Robert E. WaltermireSenior VP, Chief Pharma Dev
SellMadrigal Pharmaceuticals
Sell
Madrigal Pharmaceuticals
MDGL
$486.8K
1,412 sh
$486.8K
Filed 25/03/07
Traded 25/03/05
Robert E. WaltermireSenior VP, Chief Pharma Dev
SellMadrigal Pharmaceuticals
Sell
Madrigal Pharmaceuticals
MDGL
$387.5K
1,146 sh
$387.5K
Filed 25/03/07
Traded 25/03/05